Latest market price
46.21
+1.16+2.57%
OverviewShort InterestFilings
TRAXQT88First Tracks Biotherapeutics Inc·NASDAQ
46.21+2.57%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 2026EFFECTNotice of effectiveness
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 26, 2026S-1Registration statement
Oct 20, 20268-KCurrent report
Oct 15, 20268-KCurrent report
Oct 13, 20268-KCurrent report
Sep 17, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Sep 02, 2026144Notice of proposed sale of restricted securities
Aug 18, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 13, 2026424B3Prospectus
Aug 13, 2026SC 13GBeneficial ownership statement (passive)
Aug 12, 20268-KCurrent report
Aug 12, 202610-QQuarterly report
Aug 07, 20263/AInitial statement of beneficial ownership (amended)
Aug 07, 20263/AInitial statement of beneficial ownership (amended)
Aug 07, 20263/AInitial statement of beneficial ownership (amended)
Aug 06, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 20264Statement of changes in beneficial ownership
#1 / 25 of 90
Page
▼
/ 4